MARKET

GKOS

GKOS

Glaukos Corp
NYSE
48.04
-0.14
-0.29%
After Hours: 48.04 0 0.00% 16:00 01/27 EST
OPEN
48.06
PREV CLOSE
48.18
HIGH
48.28
LOW
47.15
VOLUME
331.95K
TURNOVER
0
52 WEEK HIGH
64.49
52 WEEK LOW
33.33
MARKET CAP
2.29B
P/E (TTM)
-25.3082
1D
5D
1M
3M
1Y
5Y
Needham Sticks to Its Buy Rating for Glaukos (GKOS)
TipRanks · 2d ago
Glaukos sees positive data from mid-stage trial of dry eye treatment
Seeking Alpha · 01/10 21:45
BRIEF-Glaukos Announces Results For Idose TR Exchange Trial
Reuters · 01/10 21:29
BRIEF-Glaukos Announces Clinical Updates For Several Corneal Health Pipeline Programs
Reuters · 01/10 21:16
Glaukos Says iDose TR Exchange Trial Shows 'Favorable' Safety, Tolerability; Shares Up After Hours
Glaukos Says iDose TR Exchange Trial Shows 'Favorable' Safety, Tolerability; Shares Up After Hours
MT Newswires · 01/10 17:20
Analyst Expectations for Glaukos's Future
Benzinga · 12/28/2022 19:01
10 Analysts Have This to Say About Glaukos
Benzinga · 12/28/2022 16:01
What 10 Analyst Ratings Have To Say About Glaukos
Benzinga · 12/28/2022 15:05
More
About GKOS
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. It is focused on developing novel therapies for the treatment of glaucoma, corneal disorders, and retinal disease. Its product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products, which includes insertion of a micro-scale device or drug delivery system designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma and MIGS biosensors to measure pressure within the eye; bio-activated pharmaceuticals to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders; transdermal pharmaceuticals that are applied to the eyelid and designed to treat dry eye, presbyopia, glaucoma and other ocular surface diseases and disorders; and micro-invasive, bio-erodible sustained release drug delivery implants that are designed to elute pharmaceuticals.

Webull offers kinds of Glaukos Corp stock information, including NYSE:GKOS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GKOS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GKOS stock methods without spending real money on the virtual paper trading platform.